Mali COVID-19 Vaccine Frequently Asked Questions series

January 18, 2022/in Fact Sheet, Technical Briefs CNIECS, Johns Hopkins Center for Communication Programs, UNICEF, United States Agency for International Development Mali Français Risk Communication and Messaging, Rumors and Misinformation, Vaccines General Public, Health Workers and Facilities, Researchers, SBC Professionals/by wpengine

This FAQ series, available in French, was developed by Breakthrough ACTION Mali in collaboration with the National Communication Sub-Commission of the COVID-19 Crisis Committee. The series was distributed across a range of partners as part of the COVID-19 vaccination campaign in 2021. Content was developed in collaboration with all partners and adapts key information and messages of the World Health Organization’s COVID Vaccine FAQs and detailed SAGE recommendations to the context of Mali’s vaccine campaign, its vaccine eligible populations and available vaccine types.

The series includes:

COVID-19 vaccine FAQ for Health workers
FAQ for the general public
AstraZeneca vaccine FAQ
Johnson & Johnson/Janssen vaccine FAQ

Source: Mali COVID-19 Vaccine Frequently Asked Questions series

Johns Hopkins Center for Communication Programs

This website is made possible by the generous support of the American people through the United States Agency for International Development (USAID) under the Breakthrough ACTION Cooperative Agreement #AID-OAA-A-17-00017. Breakthrough ACTION is based at Johns Hopkins Center for Communication Programs (CCP).The contents of this website are the sole responsibility of Breakthrough ACTION and do not necessarily reflect the views of USAID, the United States Government, or Johns Hopkins University.

STAY UPDATED